Jacobs Bruce N. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$7.28M

Insider Activity of Jacobs Bruce N.

According to the SEC Form 4 filings, Jacobs Bruce N., being in a position of

  1. Chief Financial Officer at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 89580 shares for $9.96M,
    over all time since 2021-03-03, has bought 0 shares, and sold 326139 shares for $21.2M.

Biography of Jacobs Bruce N.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $9,956,0603100

Comparison of Insiders on Amount of Buys and Sells

2026-06-30SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
77,109
0.094%
$114.96$8.86M-0.52%
2026-03-04SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
4,895
0.0061%
$85.30$417,521+23.28%
2026-03-02SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
7,576
0.0092%
$88.93$673,710+17.62%
2025-09-17SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
79,220
0.1151%
$50.00$3.96M+71.11%
2025-03-03SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
7,035
0.011%
$30.45$214,219+55.65%
2024-03-04SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
3,934
0.0064%
$41.86$164,664-3.98%
2023-03-02SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
1,370
0.0022%
$31.00$42,465-24.5%
2022-01-12SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
15,000
0.0297%
$51.85$777,684-44.59%
2021-12-03SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
10,000
0.021%
$53.56$535,637-43.67%
2021-09-03SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
20,000
0.0395%
$60.12$1.2M-34.48%
2021-06-03SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
20,000
0.0442%
$46.87$937,390+10.58%
2021-03-15SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
16,390
0.0184%
$30.09$493,096-13.14%
2021-03-11SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
3,610
0.0042%
$31.08$112,186-11.4%
2021-03-08SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
20,000
0.0459%
$50.65$1.01M+6.67%
2021-03-03SaleKymera Therapeutics, Inc.
KYMR
Chief Financial Officer
40,000
0.0892%
$44.78$1.79M+17.27%
Total: 15
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.